COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,804 Articles (22,527 medRxiv, 8,277 bioRxiv)

Most recent first Previous |  Page 250: Articles 2491-2500  | Next

Long COVID is associated with severe cognitive slowing
Zhao, S., Martin, E. M., Reuken, P. A., Scholcz, A., Ganse-Dumrath, A., Srowig, A., Utech, I., Kozik, V., Radscheidt, M., Brodoehl, S., Stallmach, A., Schwab, M., Fraser, E., Finke, K., Husain, M.
10.1101/2023.12.03.23299331 — Posted: 2023-12-04
Effect of mRNA vaccination on pulmonary sequelae after mild COVID-19
Gagiannis, D., Hackenbroch, C., Zech, F., Kirchhoff, F., Bloch, W., Junghans, K., Steinestel, K.
10.1101/2023.12.03.23299330 — Posted: 2023-12-04
The potential economic impact of the updated COVID-19 mRNA fall 2023 vaccines in Japan
Fust, K., Joshi, K., Beck, E., Maschio, M., Kohli, M., Lee, A., Hagiwara, Y., Van de Velde, N., Igarashi, A.
10.1101/2023.12.04.23299402 — Posted: 2023-12-04
Epidemiological overlaps in COVID-19 and malaria within healthcare and community settings of Southern Ghana
Amegatcher, G., Acquah, M. E., Tetteh, D., Obeng, R., Debrah, E., Quist, B., Acquah-Jackson, P., Boateng, K. A., Twieku, G., Armoo, S., Awandare, G. A., Mosi, L., Narh, C. A.
10.1101/2023.12.04.23299372 — Posted: 2023-12-04
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review
Drysdale, M., Berktas, M., Gibbons, D. C., Rolland, C., Lavoie, L., Lloyd, E. J.
10.1101/2023.12.04.23299370 — Posted: 2023-12-04
Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis
Henderson, A. D., Butler-Cole, B. F., Tazare, J., Tomlinson, L. A., Marks, M., Jit, M., Briggs, A., Lin, L.-Y., Carlile, O., Bates, C., Parry, J., Bacon, S. C., Dillingham, I., Dennison, W. A., Costello, R. E., Wei, Y., Walker, A. J., Hulme, W., Goldacre, B., Mehrkar, A., MacKenna, B., Collaborative, T. O., Herrett, E., Eggo, R. M.
10.1101/2023.12.04.23299364 — Posted: 2023-12-04
Genomic Profiling and Spatial SEIR Modeling of COVID-19 Transmission in Western New York.
Bard, J. E., Jiang, N., Emerson, J., Bartz, M., Lamb, N. A., Marzullo, B. J., Pohlman, A., Boccolucci, A., Nowak, N. J., Yergeau, D. A., Crooks, A. T., Surtees, J. A.
10.1101/2023.12.03.23299353 — Posted: 2023-12-04
Hospital segregation, critical care strain, and inpatient mortality during the COVID-19 pandemic in New York City
Zhilkova, A., Alsabahi, L., Olson, D., Maru, D., Tsao, T.-Y., Morse, M.
10.1101/2023.12.04.23299393 — Posted: 2023-12-04
Assessment of the impact of the Vaccine Pass Policy on COVID-19 vaccine hesitancy and uptake among Chinese adults in Hong Kong
Wong, I. O. L., Wong, C., Mak, N., Dai, A., Xiao, J., Wu, P., Ni, M. Y., Liao, Q., Cowling, B. J.
10.1101/2023.12.03.23299354 — Posted: 2023-12-04
Identification of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir
Krismer, L., Schoeppe, H., Rauch, S., Bante, D., Sprenger, B., Naschberger, A., Costacurta, F., Fuerst, A., Sauerwein, A., Rupp, B., Kaserer, T., von Laer, D., Heilmann, E.
10.1101/2023.12.04.569917 — Posted: 2023-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).